Literature DB >> 25324536

The Ross operation in infants and children, when and how?

Magdi Yacoub1, Ismail El-Hamamsy2.   

Abstract

Entities:  

Keywords:  CARDIAC PROCEDURES AND THERAPY

Mesh:

Year:  2014        PMID: 25324536      PMCID: PMC4251164          DOI: 10.1136/heartjnl-2014-306453

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
The Ross operation is the only operation which guarantees long-term survival of the aortic valve substitute, and allows it to reproduce some of the extremely sophisticated functions of the normal living aortic valve.1 This has been shown to translate into longer survival and better quality of life in adults.2 The operation was described almost 50 years ago,3 primarily for use in growing children, to avoid anticoagulation and repeated operations. In spite of that, the exact role, timing and techniques of applying this operation for this particular group of patients are still hotly debated.4 It could be argued that application of formal decision theory could almost immediately resolve this dilemma, by constructing a decision tree based on defining outcome of alternative decisions at each node. This however, depends on the availability of accurate statistics from large databases, which simply are not available. Until recently the only available data were from small single-centre series, which were not prospective or comparative and depended heavily on the biases and experience of the particular clinicians. The Italian multicentre registry, is a welcome addition to the literature, as it describes real-life experiences in 305 infants and children, followed up for periods of up to 23 years.5 This registry provides extremely valuable information and lessons relating to when and how to apply the Ross operation in children. With regards to timing, the registry shows markedly increased mortality (27.6% for infants as opposed to 0.2% for older children) and aortic reoperation rate (20.7% vs 10.5%) in infants undergoing the Ross operation during the 1st year of life. Similar findings have been previously reported in single-centre series.6 How can that be explained? Several factors could be involved. The first relates to the very high use of additional Konno procedures in this age group (approximately in 2/3 of the patients). This technique could destabilise the pulmonary autograft, which stems from the fact that the leaflets of the pulmonary valve, unlike those of the aortic valve are directly attached to the musculature of the RV outflow (figure 1). This necessitates the insertion of the pulmonary root within the aortic ‘annulus’ during the Ross operation.7 The second possible factor could be related to the presence of a hypoplastic aortic annulus in infants, which could interfere with the insertion of the bulky pulmonary root. The use of valve conserving operations to allow the children to grow, instead of applying the Ross operation in infancy, has consistently given excellent results.8 It is interesting to note that in older children in the Registry, previous balloon valvuloplasty but not surgical valvotomy increased the risk of the Ross operation, supporting the application of surgical rather than balloon valvuloplasty in infants.9
Figure 1

(A) Histological section of a pulmonary root stained by elastic van Gieson showing the attachment of the cusps to the right ventricular outflow tract muscle and the absence of a distinct fibrous annulus. (B) Histological section through the aortic root showing a well-defined fibrous annulus linking the aortic leaflet to the media of the sinus of Valsalva.

(A) Histological section of a pulmonary root stained by elastic van Gieson showing the attachment of the cusps to the right ventricular outflow tract muscle and the absence of a distinct fibrous annulus. (B) Histological section through the aortic root showing a well-defined fibrous annulus linking the aortic leaflet to the media of the sinus of Valsalva. Another lesson to learn from the Registry relates to the finding that the subcoronary implantation was associated with higher rates of early and late aortic valve failure. This could be due to the fact that in spite of concerns regarding late dilatation, the use of a free-standing root avoids distortion and guarantees optimal relationship between the different components of the autograft valve mechanism.7 Finally, the authors report a relatively low incidence of reoperation on the homograft in the pulmonary position. This is almost certainly due to the use of large pulmonary homografts (oversizing), which we believe is necessary at all ages particularly in children to avoid late stenosis. It is hoped that lessons learned from large registries with long careful follow-up like that of the Italian multicentre registry will help in optimising the results of the Ross operation at all ages, and address the major concerns regarding the current under use of this operation.10
  10 in total

1.  The aortic outflow and root: a tale of dynamism and crosstalk.

Authors:  M H Yacoub; P J Kilner; E J Birks; M Misfeld
Journal:  Ann Thorac Surg       Date:  1999-09       Impact factor: 4.330

2.  Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial.

Authors:  Ismail El-Hamamsy; Zeynep Eryigit; Louis-Mathieu Stevens; Zubair Sarang; Robert George; Lucy Clark; Giovanni Melina; Johanna J M Takkenberg; Magdi H Yacoub
Journal:  Lancet       Date:  2010-08-03       Impact factor: 79.321

Review 3.  The Ross procedure is not the procedure of choice for the teenager requiring aortic valve replacement.

Authors:  Richard A Jonas
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2005

4.  Under-use of the Ross operation--a lost opportunity.

Authors:  Magdi H Yacoub; Ismail El-Hamamsy; Hans-Hinrich Sievers; Blase A Carabello; Robert O Bonow; Paul Stelzer; Francisco D A da Costa; Hans J Schäfers; Peter Skillington; Efstratios I Charitos; Giovanni Battista Luciani; Johanna J M Takkenberg
Journal:  Lancet       Date:  2014-08-16       Impact factor: 79.321

5.  Replacement of aortic and mitral valves with a pulmonary autograft.

Authors:  D N Ross
Journal:  Lancet       Date:  1967-11-04       Impact factor: 79.321

Review 6.  Left heart growth, function, and reintervention after balloon aortic valvuloplasty for neonatal aortic stenosis.

Authors:  Doff B McElhinney; James E Lock; John F Keane; Adrian M Moran; Steven D Colan
Journal:  Circulation       Date:  2005-02-01       Impact factor: 29.690

7.  Two decades of experience with the Ross operation in neonates, infants and children from the Italian Paediatric Ross Registry.

Authors:  Giovanni Battista Luciani; Gianluca Lucchese; Adriano Carotti; Gianluca Brancaccio; Piero Abbruzzese; Giuseppe Caianiello; Lorenzo Galletti; Gaetano Domenico Gargiulo; Stefano Maria Marianeschi; Alessandro Mazzucco; Giuseppe Faggian; Bruno Murzi; Carlo Pace Napoleone; Marco Pozzi; Lucio Zannini; Alessandro Frigiola
Journal:  Heart       Date:  2014-07-23       Impact factor: 5.994

8.  Outcome of surgical commissurotomy for aortic valve stenosis in early infancy.

Authors:  Pia Rehnström; Torsten Malm; Peeter Jögi; Eva Fernlund; Per Winberg; Jens Johansson; Sune Johansson
Journal:  Ann Thorac Surg       Date:  2007-08       Impact factor: 4.330

9.  Ross procedure in children: 17-year experience at a single institution.

Authors:  Sharman P Tan Tanny; Matthew S Yong; Yves d'Udekem; Remi Kowalski; Gavin Wheaton; Luigi D'Orsogna; John C Galati; Christian P Brizard; Igor E Konstantinov
Journal:  J Am Heart Assoc       Date:  2013-04-19       Impact factor: 5.501

Review 10.  The living aortic valve: From molecules to function.

Authors:  Adrian H Chester; Ismail El-Hamamsy; Jonathan T Butcher; Najma Latif; Sergio Bertazzo; Magdi H Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2014-01-29
  10 in total
  1 in total

1.  The Ross procedure in children: a systematic review.

Authors:  Morgan K Moroi; Emile A Bacha; David M Kalfa
Journal:  Ann Cardiothorac Surg       Date:  2021-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.